BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pluta KD, Samluk A, Wencel A, Zakrzewska KE, Gora M, Burzynska B, Ciezkowska M, Motyl J, Pijanowska DG. Genetically modified C3A cells with restored urea cycle for improved bioartificial liver. Biocybernetics and Biomedical Engineering 2020;40:378-87. [DOI: 10.1016/j.bbe.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Pluta KD, Ciezkowska M, Wisniewska M, Wencel A, Pijanowska DG. Cell-based clinical and experimental methods for assisting the function of impaired livers – Present and future of liver support systems. Biocybernetics and Biomedical Engineering 2021;41:1322-46. [DOI: 10.1016/j.bbe.2021.06.005] [Reference Citation Analysis]
2 Coltman NJ, Coke BA, Chatzi K, Shepherd EL, Lalor PF, Schulz-Utermoehl T, Hodges NJ. Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies. Toxicol Lett 2021;345:34-45. [PMID: 33865918 DOI: 10.1016/j.toxlet.2021.04.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wencel A, Ciezkowska M, Wisniewska M, Zakrzewska KE, Pijanowska DG, Pluta KD. Effects of genetically modified human skin fibroblasts, stably overexpressing hepatocyte growth factor, on hepatic functions of cocultured C3A cells. Biotechnol Bioeng 2021;118:72-81. [PMID: 32880912 DOI: 10.1002/bit.27551] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]